Skip to main content

Table 1 Baseline characteristic of patients

From: The uniportal VATS in the treatment of stage II pleural empyema: a safe and effective approach for adults and elderly patients—a single-center experience and literature review

Variables

N. (%) and/or Mean ± SD

Total population (n. = 29)

Adults (age < 70; n. = 15)

Elderly (age ≥ 70; n. = 14)

p value

Age (years)

67.13 ± 9.96

59.84 ± 5.34

76.51 ± 5.25

 < 0.001

Gender

   

0.035

 Male

21 (72.41)

8 (53.33)

13 (92.86)

 

 Female

8 (27.59)

7 (46.67)

1 (7.14)

 

ASA

   

0.017

 II

12 (41.38)

8 (53.33)

4 (28.57)

 

 III

11 (37.93)

7 (46.67)

4 (28.57)

 

 IV

6 (20.69)

0 (0)

6 (42.86)

 

Smoker

13 (44.83)

7 (46.67)

6 (42.86)

0.873

Comorbidities

    

 Hypertension

20 (68.96)

10 (66.67)

10 (71.42)

 

 COPD

10 (34.48)

2 (13.33)

8 (57.14)

0.021

 Heart disease

10 (34.48)

2 (13.33)

8 (57.14)

0.021

 Diabetes

4 (13.79)

2 (13.33)

2 (14.29)

 

SARS-CoV-2 swab positivity

0 (0)

0 (0)

0 (0)

 

Pleural empyema stage

    

 I

0 (0)

0 (0)

0 (0)

 

 II

29 (100)

15 (100)

14 (100)

 

 III

0 (0)

0 (0)

0 (0)

 

Affected lung

    

 Left

20 (68.97)

12 (80.00)

8 (57.14)

 

 Right

9 (31.03)

3 (20.00)

6 (42.86)

 
  1. SD, standard deviation; ASA, American Society of Anaesthesiologists Physical Score; COPD, chronic obstructive pulmonary disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
Back to article page

World Journal of Emergency Surgery

ISSN: 1749-7922